98-17075. Ophthalmic Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting  

  • [Federal Register Volume 63, Number 123 (Friday, June 26, 1998)]
    [Notices]
    [Page 34902]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-17075]
    
    
    
    [[Page 34902]]
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    Ophthalmic Devices Panel of the Medical Devices Advisory 
    Committee; Notice of Meeting
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
        This notice announces a forthcoming meeting of a public advisory 
    committee of the Food and Drug Administration (FDA). The meeting will 
    be open to the public.
        Name of Committee: Ophthalmic Devices Panel of the Medical Devices 
    Advisory Committee.
        General Function of the Committee: To provide advice and 
    recommendations to the agency on FDA's regulatory issues.
        Date and Time: The meeting will be held on July 23, 1998, 8 a.m. to 
    5 p.m.
        Location: Holiday Inn, Ballroom, Two Montgomery Village Ave., 
    Gaithersburg, MD.
        Contact Person: Sara M. Thornton, Center for Devices and 
    Radiological Health (HFZ-460), Food and Drug Administration, 9200 
    Corporate Blvd., Rockville, MD 20850, or FDA Advisory Committee 
    Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
    area), code 12396. Please call the Information Line for up-to-date 
    information on this meeting.
        Agenda: The committee will discuss: (1) Premarket approval 
    application (PMA) for a toric intraocular lens for primary implantation 
    for the visual correction of aphakia, and (2) PMA for an excimer laser 
    for the surgical correction of hyperopia, sphere only, using 
    photorefractive keratectomy.
        Procedure: Interested persons may present data, information, or 
    views, orally or in writing, on issues pending before the committee. 
    Written submissions may be made to the contact person by July 15, 1998. 
    Oral presentations from the public will be scheduled between 
    approximately 8:30 a.m. and 9 a.m. An additional 30-minute time period 
    will be given for public comment at the end of committee discussion and 
    prior to voting on each PMA. Time allotted for each presentation may be 
    limited. Those desiring to make formal oral presentations should notify 
    the contact person before July 12, 1998, and submit a brief statement 
    of the general nature of the evidence or arguments they wish to 
    present, the names and addresses of proposed participants, and an 
    indication of the approximate time requested to make their 
    presentation.
        Notice of this meeting is given under the Federal Advisory 
    Committee Act (5 U.S.C. app. 2).
        Dated: June 18, 1998.
    Michael A. Friedman,
    Deputy Commissioner for Operations.
    [FR Doc. 98-17075 Filed 6-25-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
06/26/1998
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
98-17075
Pages:
34902-34902 (1 pages)
PDF File:
98-17075.pdf